CLS Holdings USA, Inc.Announces November Results With Record Gross Margin

LAS VEGAS – CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH), the “Company” or “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, today announced the financial and operating results of its Nevada wholly owned subsidiaries for the month of November 2021 with net income of $ 1.8M and a gross margin of 56%.

This represented a significant monthly gross margin increase of 20% year-over-year and 66% from 2019, as well as the largest gross margin the Company has ever achieved. City Trees’ wholesale division remained dynamic with monthly net sales growth of 91% year on year and 132% in 2019.

CLS Nevada November 2021 Financial and operational highlights

The Company’s retail division, Oasis Cannabis, continued to exceed its target of more than $ 50 average order size with average orders $ 54 in November

The company’s branded division, City Trees, continued to outperform the market and recorded a 91% year-over-year increase in revenue and a 132% increase from 2019.

City Trees continued to maintain its position as the number one dye brand in the state of Nevada

The Company Achieves Its Largest Monthly Gross Profit Margin To Date

BDS Analytics figures reflected that City Trees was the number one brand for the entire category of unit concentrates sold in the state of Nevada in October, selling over 46,000 units.

“It has been an exciting year 2021,” said the president and chief operating officer of the company Andrew Glashow. “We’re all systems going at this point. With our innovation lab producing what we believe to be the best quality product in the state of Nevada, an increasing number of consumers continue to purchase City Trees and come to our OASIS dispensary, we are poised for continued growth in ’22. The future looks bright at CLS! ‘

On CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its subsidiaries Oasis Cannabis in Nevada and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the company’s patented method of extracting various cannabinoids from the marijuana plant and converting them into products of a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, product sales, branding and advisory services.

Oasis Cannabis

Oasis Cannabis operated a cannabis dispensary in the Las Vegas market since the opening of dispensaries in Nevada in 2015 and was recognized as one of the state’s top marijuana retailers. Its location within walking distance of the Las Vegas Strip and Las Vegas downtown in combination with its delivery service to residents allows it to efficiently serve locals and tourists in the Las Vegas region. In February 2019, it was named “Best Dispensary for Pot Pros” by Desert Companion Magazine. In august 2017, the company began to wholesale cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.

Forward-looking statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” as such term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the “forward-looking statements” ). These statements concern, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and our community during the pandemic, the effect of our initiatives to expanding market share and achieving growth during and after the pandemic, operating results and financial performance, anticipated future events and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases has already had, a negative impact on our business, operations and financial results, including disrupting our growing and processing activities, supply chains and our sales channels; and retail dispensary operations. as well as a deterioration in general economic conditions, including a possible national or global recession. Due to the uncertainties associated with the continued spread of COVID-19 and the timing of vaccinations, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be significant. In some cases, you can identify forward-looking statements by words such as “may”, “could”, “will”, “should”, “the intention”, “expects”, “plans”, “the objectives ”,“ projects ”,“ anticipates ”,“ believes ”,“ estimates ”,“ predicts ”,“ potential ”or“ continues ”or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial risks, uncertainties and other known and unknown factors that may cause our actual results, levels of activity or performance to differ materially from the results, levels. activity or future performance expressed. or implied by these forward-looking statements. We cannot guarantee future results, activity levels or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. These cautions should be considered in conjunction with any written or oral forward-looking statements that we may issue in the future.

Contact:

Jeff binder

Phone. : 888-438-9132

Email: investors@clsholdingsinc.com